Correlation between PD-L1 and Tregs in tumor immunity and immunotherapy
10.3760/cma.j.cn371439-20200907-00066
- VernacularTitle:PD-L1与Treg在肿瘤免疫及治疗中的相关性
- Author:
Huiyi OU
1
;
Yue WANG
;
Chenghong PENG
Author Information
1. 上海交通大学医学院附属瑞金医院外科胰腺中心 200025
- Keywords:
Tumor escape;
T-lymphocytes, regulatory;
PD-1/PD-L1;
Immunotherapy
- From:
Journal of International Oncology
2021;48(6):350-353
- CountryChina
- Language:Chinese
-
Abstract:
Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) are important co-inhibitory molecules, while regulatory T cells (Tregs) are important suppressor cells. The increase of them in tumor microenvironment is closely related to tumor immune escape and tumor development. PD-L1 plays an important role in the development and function of Tregs. The application of PD-1/PD-L1 blockade also affects the proliferation and function of Tregs, which further participates in the occurrence of drug resistance and hyperprogressive disease. Further understanding of the role and correlation of PD-L1 and Tregs in tumor immunity and immunotherapy can provide new ideas for improving the efficacy of PD-1/PD-L1 blockade.